Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric M Horwitz

Showing results (31-40 of 192) with videos related to

Pageof 20
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Advantages of using noncoplanar vs. axial beam arrangements when treating prostate cancer with intensity-modulated radiation therapy and the step-and-shoot delivery methodRobert A Price, Gerald E Hanks, Shawn W McNeeley, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapyAlan Pollack, Alexandra L Hanlon, Benjamin Movsas, et al.
Cancer|February 6, 2003
Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapyWayne H Pinover, Eric M Horwitz, Alexandra L Hanlon, et al.
World Journal of Urology|September 10, 2003
Radiation therapy dose escalation for prostate cancer: a rationale for IMRTAlan Pollack, Alex Hanlon, Eric M Horwitz, et al.
Physics in Medicine and Biology|June 27, 2013
Reduction of prostate intrafractional motion from shortening the treatment timeJin Sheng Li, Mu-Han Lin, Mark K Buyyounouski, et al.
Future Oncology (London, England)|July 30, 2016
ASTRO APEx<sup>®</sup> and RO-ILS™ are applicable to medical malpractice in radiation oncologyNicholas G Zaorsky, Anthony G Ricco, Thomas M Churilla, et al.
BJU International|June 26, 2004
Matched-cohort analysis of patients with prostate cancer followed with observation or treated with three-dimensional conformal radiation therapyNoel M Kramer, Eric M Horwitz, Robert G Uzzo, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2005
Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvementRojymon Jacob, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2011
Hypoxic prostate/muscle PO2 ratio predicts for outcome in patients with localized prostate cancer: long-term resultsAruna Turaka, Mark K Buyyounouski, Alexandra L Hanlon, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
How can men destined for biochemical failure after androgen deprivation and radiotherapy be identified earlier?David J D'Ambrosio, Karen Ruth, Eric M Horwitz, et al.
Pageof 20

Showing results (31-40 of 192) with videos related to

Sort By:
Pageof 20
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Advantages of using noncoplanar vs. axial beam arrangements when treating prostate cancer with intensity-modulated radiation therapy and the step-and-shoot delivery methodRobert A Price, Gerald E Hanks, Shawn W McNeeley, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapyAlan Pollack, Alexandra L Hanlon, Benjamin Movsas, et al.
Cancer|February 6, 2003
Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapyWayne H Pinover, Eric M Horwitz, Alexandra L Hanlon, et al.
World Journal of Urology|September 10, 2003
Radiation therapy dose escalation for prostate cancer: a rationale for IMRTAlan Pollack, Alex Hanlon, Eric M Horwitz, et al.
Physics in Medicine and Biology|June 27, 2013
Reduction of prostate intrafractional motion from shortening the treatment timeJin Sheng Li, Mu-Han Lin, Mark K Buyyounouski, et al.
Future Oncology (London, England)|July 30, 2016
ASTRO APEx<sup>®</sup> and RO-ILS™ are applicable to medical malpractice in radiation oncologyNicholas G Zaorsky, Anthony G Ricco, Thomas M Churilla, et al.
BJU International|June 26, 2004
Matched-cohort analysis of patients with prostate cancer followed with observation or treated with three-dimensional conformal radiation therapyNoel M Kramer, Eric M Horwitz, Robert G Uzzo, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2005
Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvementRojymon Jacob, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2011
Hypoxic prostate/muscle PO2 ratio predicts for outcome in patients with localized prostate cancer: long-term resultsAruna Turaka, Mark K Buyyounouski, Alexandra L Hanlon, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
How can men destined for biochemical failure after androgen deprivation and radiotherapy be identified earlier?David J D'Ambrosio, Karen Ruth, Eric M Horwitz, et al.
Pageof 20